

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.08775100 |
| 2 | viral transcription (GO:0019083) | 5.93854131 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 5.85299960 |
| 4 | translational termination (GO:0006415) | 5.77727416 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.74417463 |
| 6 | chaperone-mediated protein transport (GO:0072321) | 5.38650988 |
| 7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.29042822 |
| 8 | respiratory electron transport chain (GO:0022904) | 5.24075686 |
| 9 | protein complex biogenesis (GO:0070271) | 5.19206473 |
| 10 | cotranslational protein targeting to membrane (GO:0006613) | 5.18666359 |
| 11 | electron transport chain (GO:0022900) | 5.17825543 |
| 12 | protein targeting to ER (GO:0045047) | 5.17287913 |
| 13 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 5.04125612 |
| 14 | NADH dehydrogenase complex assembly (GO:0010257) | 5.04125612 |
| 15 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 5.04125612 |
| 16 | translational elongation (GO:0006414) | 5.03168003 |
| 17 | maturation of SSU-rRNA (GO:0030490) | 5.02881050 |
| 18 | DNA deamination (GO:0045006) | 4.94269178 |
| 19 | protein localization to endoplasmic reticulum (GO:0070972) | 4.91031623 |
| 20 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.90450556 |
| 21 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.88481332 |
| 22 | ribosomal large subunit biogenesis (GO:0042273) | 4.81901218 |
| 23 | translational initiation (GO:0006413) | 4.60962860 |
| 24 | proteasome assembly (GO:0043248) | 4.54326045 |
| 25 | viral life cycle (GO:0019058) | 4.53301055 |
| 26 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.42907253 |
| 27 | cellular protein complex disassembly (GO:0043624) | 4.42895378 |
| 28 | protein neddylation (GO:0045116) | 4.40940946 |
| 29 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.27355655 |
| 30 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.07480214 |
| 31 | * translation (GO:0006412) | 4.04584791 |
| 32 | formation of translation preinitiation complex (GO:0001731) | 3.77059504 |
| 33 | ATP biosynthetic process (GO:0006754) | 3.76130941 |
| 34 | protein complex disassembly (GO:0043241) | 3.74904157 |
| 35 | hydrogen ion transmembrane transport (GO:1902600) | 3.72328934 |
| 36 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.71796899 |
| 37 | platelet dense granule organization (GO:0060155) | 3.61557295 |
| 38 | sequestering of actin monomers (GO:0042989) | 3.61503876 |
| 39 | respiratory chain complex IV assembly (GO:0008535) | 3.60160490 |
| 40 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.58911020 |
| 41 | macromolecular complex disassembly (GO:0032984) | 3.55434841 |
| 42 | cytochrome complex assembly (GO:0017004) | 3.50866907 |
| 43 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.48822957 |
| 44 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.48486120 |
| 45 | termination of RNA polymerase III transcription (GO:0006386) | 3.48212948 |
| 46 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.48212948 |
| 47 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.48051309 |
| 48 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.46079434 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.45909011 |
| 50 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.45816341 |
| 51 | rRNA processing (GO:0006364) | 3.44656352 |
| 52 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.43930164 |
| 53 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.43827328 |
| 54 | protein targeting to membrane (GO:0006612) | 3.42331155 |
| 55 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.40031300 |
| 56 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.40031300 |
| 57 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.38594818 |
| 58 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.38177424 |
| 59 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.38177424 |
| 60 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.38177424 |
| 61 | negative regulation of ligase activity (GO:0051352) | 3.37571253 |
| 62 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.37571253 |
| 63 | ribosome assembly (GO:0042255) | 3.37277060 |
| 64 | proton transport (GO:0015992) | 3.36329154 |
| 65 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.34890931 |
| 66 | intracellular protein transmembrane import (GO:0044743) | 3.34225130 |
| 67 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.33649786 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.32581250 |
| 69 | rRNA metabolic process (GO:0016072) | 3.30904355 |
| 70 | DNA strand elongation (GO:0022616) | 3.30557869 |
| 71 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.30361114 |
| 72 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.30361114 |
| 73 | cellular component biogenesis (GO:0044085) | 3.29031763 |
| 74 | hydrogen transport (GO:0006818) | 3.28125836 |
| 75 | rRNA modification (GO:0000154) | 3.26661662 |
| 76 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.26033039 |
| 77 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.24482273 |
| 78 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.21778945 |
| 79 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.21778945 |
| 80 | CENP-A containing nucleosome assembly (GO:0034080) | 3.21195045 |
| 81 | telomere maintenance via recombination (GO:0000722) | 3.19853744 |
| 82 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.19694717 |
| 83 | ATP synthesis coupled proton transport (GO:0015986) | 3.19694717 |
| 84 | DNA replication initiation (GO:0006270) | 3.16475096 |
| 85 | ribosome biogenesis (GO:0042254) | 3.16270807 |
| 86 | mRNA catabolic process (GO:0006402) | 3.16191952 |
| 87 | pseudouridine synthesis (GO:0001522) | 3.15482994 |
| 88 | protein-cofactor linkage (GO:0018065) | 3.14283677 |
| 89 | chromatin remodeling at centromere (GO:0031055) | 3.12949102 |
| 90 | behavioral response to nicotine (GO:0035095) | 3.12408561 |
| 91 | spliceosomal snRNP assembly (GO:0000387) | 3.11022277 |
| 92 | nucleobase biosynthetic process (GO:0046112) | 3.10533428 |
| 93 | purine nucleobase biosynthetic process (GO:0009113) | 3.08483828 |
| 94 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.07485436 |
| 95 | DNA replication checkpoint (GO:0000076) | 3.05696392 |
| 96 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.05466995 |
| 97 | establishment of integrated proviral latency (GO:0075713) | 3.01071119 |
| 98 | RNA catabolic process (GO:0006401) | 2.98157940 |
| 99 | positive regulation of ligase activity (GO:0051351) | 2.97473283 |
| 100 | mitotic metaphase plate congression (GO:0007080) | 2.95330622 |
| 101 | 7-methylguanosine mRNA capping (GO:0006370) | 2.92803383 |
| 102 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.91435218 |
| 103 | kinetochore assembly (GO:0051382) | 2.90338296 |
| 104 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.89975683 |
| 105 | signal peptide processing (GO:0006465) | 2.89678598 |
| 106 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.89628545 |
| 107 | RNA capping (GO:0036260) | 2.87818142 |
| 108 | 7-methylguanosine RNA capping (GO:0009452) | 2.87818142 |
| 109 | mitotic recombination (GO:0006312) | 2.86455931 |
| 110 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.85827839 |
| 111 | peptidyl-histidine modification (GO:0018202) | 2.85655105 |
| 112 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.85105522 |
| 113 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.85066626 |
| 114 | kinetochore organization (GO:0051383) | 2.83942504 |
| 115 | cell cycle G1/S phase transition (GO:0044843) | 2.82438184 |
| 116 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.82438184 |
| 117 | regulation of mitochondrial translation (GO:0070129) | 2.82264115 |
| 118 | folic acid metabolic process (GO:0046655) | 2.80340846 |
| 119 | nonmotile primary cilium assembly (GO:0035058) | 2.80123980 |
| 120 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.79909458 |
| 121 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.78550388 |
| 122 | spliceosomal complex assembly (GO:0000245) | 2.78410867 |
| 123 | mitochondrion morphogenesis (GO:0070584) | 2.77335698 |
| 124 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.77114676 |
| 125 | establishment of protein localization to mitochondrion (GO:0072655) | 2.77045995 |
| 126 | positive regulation of cell cycle arrest (GO:0071158) | 2.75131916 |
| 127 | transcription from RNA polymerase I promoter (GO:0006360) | 2.74384384 |
| 128 | protein targeting to mitochondrion (GO:0006626) | 2.74206936 |
| 129 | telomere maintenance via telomere lengthening (GO:0010833) | 2.73210072 |
| 130 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.71736881 |
| 131 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.68558404 |
| 132 | inner mitochondrial membrane organization (GO:0007007) | 2.68523896 |
| 133 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.67696617 |
| 134 | GTP biosynthetic process (GO:0006183) | 2.66993791 |
| 135 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.62517562 |
| 136 | organelle disassembly (GO:1903008) | 2.62507083 |
| 137 | sulfation (GO:0051923) | 2.62009412 |
| 138 | protein localization to mitochondrion (GO:0070585) | 2.61544699 |
| 139 | protein targeting (GO:0006605) | 2.60740813 |
| 140 | establishment of protein localization to membrane (GO:0090150) | 2.58577853 |
| 141 | mitochondrial transport (GO:0006839) | 2.56049029 |
| 142 | anterograde synaptic vesicle transport (GO:0048490) | 2.55542686 |
| 143 | mannosylation (GO:0097502) | 2.53146007 |
| 144 | rRNA methylation (GO:0031167) | 2.50770238 |
| 145 | vitamin biosynthetic process (GO:0009110) | 2.49328444 |
| 146 | oxidative phosphorylation (GO:0006119) | 2.47650764 |
| 147 | aldehyde catabolic process (GO:0046185) | 2.45203777 |
| 148 | indolalkylamine catabolic process (GO:0046218) | 2.43820589 |
| 149 | tryptophan catabolic process (GO:0006569) | 2.43820589 |
| 150 | indole-containing compound catabolic process (GO:0042436) | 2.43820589 |
| 151 | maturation of 5.8S rRNA (GO:0000460) | 2.43387161 |
| 152 | establishment of protein localization to organelle (GO:0072594) | 2.41842926 |
| 153 | epithelial cilium movement (GO:0003351) | 2.41341252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.01246915 |
| 2 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.35094540 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.80964579 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.75844590 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.69948941 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.44518347 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.23130824 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.10303149 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.09539171 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.09004701 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.92698202 |
| 12 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.88295615 |
| 13 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.73983754 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.65653081 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.64794732 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.54247825 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.48484510 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.46975675 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.37648639 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.35457779 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.32026742 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.31972861 |
| 23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.30905507 |
| 24 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.30857167 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 2.25477438 |
| 26 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.25368563 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.25321889 |
| 28 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.19315967 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.16959918 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 2.14041480 |
| 31 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.13294339 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 2.09854769 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.08891881 |
| 34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.98517230 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.85847871 |
| 36 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.82854402 |
| 37 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.82556443 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.82451000 |
| 39 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.77335729 |
| 40 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.76774864 |
| 41 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.71756609 |
| 42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.69011861 |
| 43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.68851662 |
| 44 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.65468527 |
| 45 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.60747142 |
| 46 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.59964891 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.59852719 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59085476 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.58646019 |
| 50 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.58591252 |
| 51 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.55288274 |
| 52 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.52828318 |
| 53 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52255738 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.50382059 |
| 55 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.50091140 |
| 56 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.50008712 |
| 57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.48532881 |
| 58 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.47814682 |
| 59 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46906899 |
| 60 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45547675 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45358421 |
| 62 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.43319174 |
| 63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.42828685 |
| 64 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.40478614 |
| 65 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.39615161 |
| 66 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.39387766 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39255125 |
| 68 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39066066 |
| 69 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.39031196 |
| 70 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36768803 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.35956762 |
| 72 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.35058013 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.35055476 |
| 74 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.33177644 |
| 75 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31614691 |
| 76 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.31540276 |
| 77 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.30367329 |
| 78 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.28560976 |
| 79 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27097122 |
| 80 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26908396 |
| 81 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23499654 |
| 82 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.21691337 |
| 83 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21274545 |
| 84 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.20559617 |
| 85 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.20559617 |
| 86 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20438868 |
| 87 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20113696 |
| 88 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.19409630 |
| 89 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18907297 |
| 90 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.18893001 |
| 91 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.17879796 |
| 92 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.15090170 |
| 93 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14821214 |
| 94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14728145 |
| 95 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.14182389 |
| 96 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.12854800 |
| 97 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12621582 |
| 98 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11721192 |
| 99 | AR_20517297_ChIP-Seq_VCAP_Human | 1.11477957 |
| 100 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09875580 |
| 101 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09409143 |
| 102 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.08390078 |
| 103 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.08390078 |
| 104 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.07689337 |
| 105 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.07643761 |
| 106 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06996509 |
| 107 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06433270 |
| 108 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04784864 |
| 109 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04729304 |
| 110 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04623523 |
| 111 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02984913 |
| 112 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02119789 |
| 113 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.01553754 |
| 114 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01401018 |
| 115 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01281976 |
| 116 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.01257290 |
| 117 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01186877 |
| 118 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.01163727 |
| 119 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.00844435 |
| 120 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00068770 |
| 121 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.99681077 |
| 122 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.98788661 |
| 123 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.98786324 |
| 124 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.96965061 |
| 125 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96950308 |
| 126 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96160432 |
| 127 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.96037265 |
| 128 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95651280 |
| 129 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.95439388 |
| 130 | * MYC_18940864_ChIP-ChIP_HL60_Human | 0.95131612 |
| 131 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94968904 |
| 132 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.94455012 |
| 133 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91834146 |
| 134 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91154686 |
| 135 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91150252 |
| 136 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.90737587 |
| 137 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.90634149 |
| 138 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.90285955 |
| 139 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90282295 |
| 140 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.90210537 |
| 141 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89994649 |
| 142 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.89353430 |
| 143 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.89289812 |
| 144 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.88518644 |
| 145 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.88365916 |
| 146 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.88365916 |
| 147 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.88365916 |
| 148 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86422029 |
| 149 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.86409562 |
| 150 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85302441 |
| 151 | AR_25329375_ChIP-Seq_VCAP_Human | 0.85040974 |
| 152 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.84945222 |
| 153 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.84296652 |
| 154 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.80594599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.52002350 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.09031298 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 3.47740799 |
| 4 | MP0003186_abnormal_redox_activity | 2.95864511 |
| 5 | MP0006292_abnormal_olfactory_placode | 2.88847185 |
| 6 | MP0003077_abnormal_cell_cycle | 2.68352913 |
| 7 | MP0009379_abnormal_foot_pigmentation | 2.67387795 |
| 8 | MP0003111_abnormal_nucleus_morphology | 2.60340215 |
| 9 | MP0010094_abnormal_chromosome_stability | 2.60034161 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.34803910 |
| 11 | MP0008057_abnormal_DNA_replication | 2.33693523 |
| 12 | MP0003011_delayed_dark_adaptation | 2.29792914 |
| 13 | MP0003718_maternal_effect | 2.26725793 |
| 14 | MP0008932_abnormal_embryonic_tissue | 2.21809784 |
| 15 | MP0005171_absent_coat_pigmentation | 2.17717323 |
| 16 | MP0002653_abnormal_ependyma_morphology | 2.06336401 |
| 17 | MP0008007_abnormal_cellular_replicative | 2.04055414 |
| 18 | MP0008058_abnormal_DNA_repair | 2.01974578 |
| 19 | MP0006072_abnormal_retinal_apoptosis | 1.97965067 |
| 20 | MP0004142_abnormal_muscle_tone | 1.90347284 |
| 21 | MP0003941_abnormal_skin_development | 1.78857737 |
| 22 | MP0008789_abnormal_olfactory_epithelium | 1.77883399 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.71839239 |
| 24 | MP0000372_irregular_coat_pigmentation | 1.70058816 |
| 25 | MP0002102_abnormal_ear_morphology | 1.64986384 |
| 26 | MP0010386_abnormal_urinary_bladder | 1.63123051 |
| 27 | MP0005503_abnormal_tendon_morphology | 1.61936430 |
| 28 | MP0001485_abnormal_pinna_reflex | 1.61725444 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.60722684 |
| 30 | MP0005551_abnormal_eye_electrophysiolog | 1.57974368 |
| 31 | MP0003786_premature_aging | 1.55865370 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.55582985 |
| 33 | MP0000490_abnormal_crypts_of | 1.53976004 |
| 34 | MP0002132_abnormal_respiratory_system | 1.49435483 |
| 35 | MP0001529_abnormal_vocalization | 1.49236484 |
| 36 | MP0009785_altered_susceptibility_to | 1.48927492 |
| 37 | MP0001853_heart_inflammation | 1.48516422 |
| 38 | MP0005408_hypopigmentation | 1.46551466 |
| 39 | MP0002638_abnormal_pupillary_reflex | 1.46443943 |
| 40 | MP0000049_abnormal_middle_ear | 1.44776478 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.42974940 |
| 42 | MP0002095_abnormal_skin_pigmentation | 1.42940065 |
| 43 | MP0009250_abnormal_appendicular_skeleto | 1.42317160 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.40452570 |
| 45 | MP0001835_abnormal_antigen_presentation | 1.39428631 |
| 46 | MP0002282_abnormal_trachea_morphology | 1.38370387 |
| 47 | MP0003136_yellow_coat_color | 1.36122513 |
| 48 | MP0002160_abnormal_reproductive_system | 1.35638311 |
| 49 | MP0006036_abnormal_mitochondrial_physio | 1.32530393 |
| 50 | MP0000350_abnormal_cell_proliferation | 1.32285227 |
| 51 | MP0005253_abnormal_eye_physiology | 1.31540592 |
| 52 | MP0003937_abnormal_limbs/digits/tail_de | 1.30544446 |
| 53 | MP0003252_abnormal_bile_duct | 1.30401738 |
| 54 | MP0003283_abnormal_digestive_organ | 1.29440095 |
| 55 | MP0003436_decreased_susceptibility_to | 1.28736527 |
| 56 | MP0002139_abnormal_hepatobiliary_system | 1.28493374 |
| 57 | MP0002234_abnormal_pharynx_morphology | 1.26952420 |
| 58 | MP0000858_altered_metastatic_potential | 1.25755441 |
| 59 | MP0001730_embryonic_growth_arrest | 1.24831838 |
| 60 | MP0000631_abnormal_neuroendocrine_gland | 1.24081855 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.23724203 |
| 62 | MP0010030_abnormal_orbit_morphology | 1.21479539 |
| 63 | MP0005360_urolithiasis | 1.18409834 |
| 64 | MP0000026_abnormal_inner_ear | 1.15567894 |
| 65 | MP0005195_abnormal_posterior_eye | 1.14671242 |
| 66 | MP0005085_abnormal_gallbladder_physiolo | 1.14148149 |
| 67 | MP0001286_abnormal_eye_development | 1.13494003 |
| 68 | MP0004147_increased_porphyrin_level | 1.12993540 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 1.12722975 |
| 70 | MP0003950_abnormal_plasma_membrane | 1.12554912 |
| 71 | MP0002019_abnormal_tumor_incidence | 1.12021460 |
| 72 | MP0002396_abnormal_hematopoietic_system | 1.09951830 |
| 73 | MP0009384_cardiac_valve_regurgitation | 1.09250220 |
| 74 | MP0005083_abnormal_biliary_tract | 1.08223989 |
| 75 | MP0002736_abnormal_nociception_after | 1.07788929 |
| 76 | MP0009053_abnormal_anal_canal | 1.07410288 |
| 77 | MP0001324_abnormal_eye_pigmentation | 1.07295725 |
| 78 | MP0002751_abnormal_autonomic_nervous | 1.05473626 |
| 79 | MP0000313_abnormal_cell_death | 1.03990574 |
| 80 | MP0000358_abnormal_cell_content/ | 1.02511865 |
| 81 | MP0005451_abnormal_body_composition | 1.01663157 |
| 82 | MP0009840_abnormal_foam_cell | 1.01540524 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 1.01521042 |
| 84 | MP0001764_abnormal_homeostasis | 1.00562025 |
| 85 | MP0005025_abnormal_response_to | 1.00428629 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 0.99968612 |
| 87 | MP0001905_abnormal_dopamine_level | 0.98987240 |
| 88 | MP0003755_abnormal_palate_morphology | 0.98519271 |
| 89 | MP0003890_abnormal_embryonic-extraembry | 0.96636462 |
| 90 | MP0008872_abnormal_physiological_respon | 0.95766686 |
| 91 | MP0005501_abnormal_skin_physiology | 0.95526071 |
| 92 | MP0000685_abnormal_immune_system | 0.94273679 |
| 93 | MP0002295_abnormal_pulmonary_circulatio | 0.93065300 |
| 94 | MP0006054_spinal_hemorrhage | 0.92979713 |
| 95 | MP0005391_vision/eye_phenotype | 0.92702706 |
| 96 | MP0005397_hematopoietic_system_phenotyp | 0.92561711 |
| 97 | MP0001545_abnormal_hematopoietic_system | 0.92561711 |
| 98 | MP0002138_abnormal_hepatobiliary_system | 0.92477471 |
| 99 | MP0001666_abnormal_nutrient_absorption | 0.92235826 |
| 100 | MP0002796_impaired_skin_barrier | 0.91655303 |
| 101 | MP0002090_abnormal_vision | 0.91547143 |
| 102 | MP0000647_abnormal_sebaceous_gland | 0.90896702 |
| 103 | MP0002233_abnormal_nose_morphology | 0.90072559 |
| 104 | MP0002163_abnormal_gland_morphology | 0.89428935 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.89224880 |
| 106 | MP0001697_abnormal_embryo_size | 0.88953910 |
| 107 | MP0001542_abnormal_bone_strength | 0.87817809 |
| 108 | MP0004381_abnormal_hair_follicle | 0.87584325 |
| 109 | MP0005000_abnormal_immune_tolerance | 0.87128904 |
| 110 | MP0003724_increased_susceptibility_to | 0.85911795 |
| 111 | MP0010307_abnormal_tumor_latency | 0.85437622 |
| 112 | MP0004133_heterotaxia | 0.85022855 |
| 113 | MP0008469_abnormal_protein_level | 0.84911396 |
| 114 | MP0002080_prenatal_lethality | 0.83597749 |
| 115 | MP0000566_synostosis | 0.83084027 |
| 116 | MP0000427_abnormal_hair_cycle | 0.82789265 |
| 117 | MP0003195_calcinosis | 0.82693585 |
| 118 | MP0005379_endocrine/exocrine_gland_phen | 0.82509490 |
| 119 | MP0005499_abnormal_olfactory_system | 0.82412977 |
| 120 | MP0005394_taste/olfaction_phenotype | 0.82412977 |
| 121 | MP0005395_other_phenotype | 0.82289637 |
| 122 | MP0005671_abnormal_response_to | 0.82096950 |
| 123 | MP0001299_abnormal_eye_distance/ | 0.81133013 |
| 124 | MP0002697_abnormal_eye_size | 0.80994676 |
| 125 | MP0001984_abnormal_olfaction | 0.80510488 |
| 126 | MP0009697_abnormal_copulation | 0.79284447 |
| 127 | MP0005023_abnormal_wound_healing | 0.78046015 |
| 128 | MP0003938_abnormal_ear_development | 0.77984141 |
| 129 | MP0000538_abnormal_urinary_bladder | 0.77936002 |
| 130 | MP0004885_abnormal_endolymph | 0.77637849 |
| 131 | MP0005266_abnormal_metabolism | 0.76918060 |
| 132 | MP0002722_abnormal_immune_system | 0.76915062 |
| 133 | MP0005365_abnormal_bile_salt | 0.76751569 |
| 134 | MP0003315_abnormal_perineum_morphology | 0.76066245 |
| 135 | MP0005332_abnormal_amino_acid | 0.75929496 |
| 136 | MP0005220_abnormal_exocrine_pancreas | 0.75881261 |
| 137 | MP0005380_embryogenesis_phenotype | 0.75526118 |
| 138 | MP0001672_abnormal_embryogenesis/_devel | 0.75526118 |
| 139 | MP0002419_abnormal_innate_immunity | 0.75339968 |
| 140 | MP0002928_abnormal_bile_duct | 0.75028178 |
| 141 | MP0002938_white_spotting | 0.75008803 |
| 142 | MP0009643_abnormal_urine_homeostasis | 0.74542234 |
| 143 | MP0000689_abnormal_spleen_morphology | 0.74312802 |
| 144 | MP0000750_abnormal_muscle_regeneration | 0.74094678 |
| 145 | MP0004019_abnormal_vitamin_homeostasis | 0.73623312 |
| 146 | MP0002452_abnormal_antigen_presenting | 0.73166196 |
| 147 | MP0001293_anophthalmia | 0.73012566 |
| 148 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72157530 |
| 149 | MP0001243_abnormal_dermal_layer | 0.72143079 |
| 150 | MP0009764_decreased_sensitivity_to | 0.72043049 |
| 151 | MP0000627_abnormal_mammary_gland | 0.72031270 |
| 152 | MP0006276_abnormal_autonomic_nervous | 0.71827781 |
| 153 | MP0002060_abnormal_skin_morphology | 0.71355294 |
| 154 | MP0005636_abnormal_mineral_homeostasis | 0.71321638 |
| 155 | MP0005389_reproductive_system_phenotype | 0.71319556 |
| 156 | MP0005187_abnormal_penis_morphology | 0.71274690 |
| 157 | MP0004043_abnormal_pH_regulation | 0.71150827 |
| 158 | MP0002723_abnormal_immune_serum | 0.71109231 |
| 159 | MP0004742_abnormal_vestibular_system | 0.71095713 |
| 160 | MP0001845_abnormal_inflammatory_respons | 0.70518314 |
| 161 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70297425 |
| 162 | MP0002752_abnormal_somatic_nervous | 0.70252429 |
| 163 | MP0002006_tumorigenesis | 0.70043593 |
| 164 | MP0008438_abnormal_cutaneous_collagen | 0.69941834 |
| 165 | MP0002098_abnormal_vibrissa_morphology | 0.69266092 |
| 166 | MP0005646_abnormal_pituitary_gland | 0.68899898 |
| 167 | MP0002405_respiratory_system_inflammati | 0.68609148 |
| 168 | MP0003646_muscle_fatigue | 0.68474526 |
| 169 | MP0002429_abnormal_blood_cell | 0.68361597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.27082103 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.63010950 |
| 3 | Reticulocytopenia (HP:0001896) | 5.20262003 |
| 4 | Macrocytic anemia (HP:0001972) | 4.36940785 |
| 5 | Pallor (HP:0000980) | 3.80851948 |
| 6 | Pancreatic cysts (HP:0001737) | 3.78627709 |
| 7 | Birth length less than 3rd percentile (HP:0003561) | 3.66210738 |
| 8 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.57677214 |
| 9 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.57677214 |
| 10 | Pancreatic fibrosis (HP:0100732) | 3.57513184 |
| 11 | Abnormality of midbrain morphology (HP:0002418) | 3.54134193 |
| 12 | Molar tooth sign on MRI (HP:0002419) | 3.54134193 |
| 13 | True hermaphroditism (HP:0010459) | 3.48384615 |
| 14 | Oral leukoplakia (HP:0002745) | 3.33135921 |
| 15 | Breast hypoplasia (HP:0003187) | 3.27780118 |
| 16 | Acute necrotizing encephalopathy (HP:0006965) | 3.27393725 |
| 17 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.25645694 |
| 18 | Increased hepatocellular lipid droplets (HP:0006565) | 3.14202811 |
| 19 | 3-Methylglutaconic aciduria (HP:0003535) | 3.12763101 |
| 20 | Mitochondrial inheritance (HP:0001427) | 3.11700722 |
| 21 | Rough bone trabeculation (HP:0100670) | 3.05220943 |
| 22 | Aplastic anemia (HP:0001915) | 3.04521392 |
| 23 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.00908051 |
| 24 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.95995690 |
| 25 | Lipid accumulation in hepatocytes (HP:0006561) | 2.95888873 |
| 26 | Abnormal hemoglobin (HP:0011902) | 2.95547035 |
| 27 | Hepatic necrosis (HP:0002605) | 2.94420159 |
| 28 | Exertional dyspnea (HP:0002875) | 2.94246809 |
| 29 | Acute encephalopathy (HP:0006846) | 2.88912480 |
| 30 | Hepatocellular necrosis (HP:0001404) | 2.84931820 |
| 31 | Increased CSF lactate (HP:0002490) | 2.83797484 |
| 32 | Nephronophthisis (HP:0000090) | 2.82310101 |
| 33 | Carpal bone hypoplasia (HP:0001498) | 2.79840775 |
| 34 | Multiple enchondromatosis (HP:0005701) | 2.79590786 |
| 35 | Medial flaring of the eyebrow (HP:0010747) | 2.75479653 |
| 36 | Trismus (HP:0000211) | 2.73025557 |
| 37 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.70229800 |
| 38 | Septo-optic dysplasia (HP:0100842) | 2.66750943 |
| 39 | Renal Fanconi syndrome (HP:0001994) | 2.65401582 |
| 40 | Increased serum lactate (HP:0002151) | 2.61654817 |
| 41 | Cerebral edema (HP:0002181) | 2.59635558 |
| 42 | Poor head control (HP:0002421) | 2.53500924 |
| 43 | Sclerocornea (HP:0000647) | 2.50592066 |
| 44 | Optic disc pallor (HP:0000543) | 2.49499665 |
| 45 | Increased intramyocellular lipid droplets (HP:0012240) | 2.44976462 |
| 46 | Microretrognathia (HP:0000308) | 2.44045027 |
| 47 | Methylmalonic acidemia (HP:0002912) | 2.43585317 |
| 48 | Progressive macrocephaly (HP:0004481) | 2.43346326 |
| 49 | Type I transferrin isoform profile (HP:0003642) | 2.42024493 |
| 50 | Sparse eyelashes (HP:0000653) | 2.41840842 |
| 51 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.41755968 |
| 52 | Abnormality of alanine metabolism (HP:0010916) | 2.41000535 |
| 53 | Hyperalaninemia (HP:0003348) | 2.41000535 |
| 54 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.41000535 |
| 55 | Methylmalonic aciduria (HP:0012120) | 2.39144587 |
| 56 | Abnormal trabecular bone morphology (HP:0100671) | 2.37010937 |
| 57 | Congenital, generalized hypertrichosis (HP:0004540) | 2.33040410 |
| 58 | Abnormality of the renal medulla (HP:0100957) | 2.31349048 |
| 59 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.29358087 |
| 60 | Nausea (HP:0002018) | 2.28146377 |
| 61 | Microvesicular hepatic steatosis (HP:0001414) | 2.28030483 |
| 62 | Reduced antithrombin III activity (HP:0001976) | 2.27444835 |
| 63 | Stenosis of the external auditory canal (HP:0000402) | 2.21257365 |
| 64 | Hyperglycinemia (HP:0002154) | 2.20752612 |
| 65 | Cerebral hypomyelination (HP:0006808) | 2.19881566 |
| 66 | Premature graying of hair (HP:0002216) | 2.17247337 |
| 67 | Increased muscle lipid content (HP:0009058) | 2.15359937 |
| 68 | Exercise intolerance (HP:0003546) | 2.14785593 |
| 69 | Lactic acidosis (HP:0003128) | 2.14708623 |
| 70 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.14033266 |
| 71 | Congenital primary aphakia (HP:0007707) | 2.13224422 |
| 72 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.10636876 |
| 73 | Leukodystrophy (HP:0002415) | 2.10518001 |
| 74 | Respiratory failure (HP:0002878) | 2.08655942 |
| 75 | Secondary amenorrhea (HP:0000869) | 2.07096417 |
| 76 | Hypoplasia of the pons (HP:0012110) | 2.06002179 |
| 77 | Absent thumb (HP:0009777) | 2.05693333 |
| 78 | Rib fusion (HP:0000902) | 2.04819661 |
| 79 | Pancytopenia (HP:0001876) | 2.04091256 |
| 80 | Abnormality of the pons (HP:0007361) | 2.03857533 |
| 81 | Cystic liver disease (HP:0006706) | 2.03242528 |
| 82 | Pendular nystagmus (HP:0012043) | 2.02626986 |
| 83 | Abnormality of serum amino acid levels (HP:0003112) | 2.02332686 |
| 84 | Gait imbalance (HP:0002141) | 2.02332650 |
| 85 | Concave nail (HP:0001598) | 2.01682916 |
| 86 | Abnormality of the anterior horn cell (HP:0006802) | 2.00116974 |
| 87 | Degeneration of anterior horn cells (HP:0002398) | 2.00116974 |
| 88 | Respiratory difficulties (HP:0002880) | 2.00041330 |
| 89 | Parakeratosis (HP:0001036) | 1.99672977 |
| 90 | Cleft eyelid (HP:0000625) | 1.98770608 |
| 91 | Abnormal biliary tract physiology (HP:0012439) | 1.98188798 |
| 92 | Bile duct proliferation (HP:0001408) | 1.98188798 |
| 93 | 11 pairs of ribs (HP:0000878) | 1.97289303 |
| 94 | Abnormality of reticulocytes (HP:0004312) | 1.96298010 |
| 95 | Nephrogenic diabetes insipidus (HP:0009806) | 1.95220205 |
| 96 | Absent radius (HP:0003974) | 1.95032997 |
| 97 | Male pseudohermaphroditism (HP:0000037) | 1.94026907 |
| 98 | Furrowed tongue (HP:0000221) | 1.93799713 |
| 99 | Optic nerve hypoplasia (HP:0000609) | 1.93767194 |
| 100 | Anencephaly (HP:0002323) | 1.93641275 |
| 101 | Congenital stationary night blindness (HP:0007642) | 1.92817643 |
| 102 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.92757986 |
| 103 | Abnormality of the renal cortex (HP:0011035) | 1.92561268 |
| 104 | Lethargy (HP:0001254) | 1.91443401 |
| 105 | Patellar aplasia (HP:0006443) | 1.90737880 |
| 106 | Increased serum pyruvate (HP:0003542) | 1.90632161 |
| 107 | Abnormality of glycolysis (HP:0004366) | 1.90632161 |
| 108 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.88990431 |
| 109 | Increased corneal curvature (HP:0100692) | 1.88269282 |
| 110 | Keratoconus (HP:0000563) | 1.88269282 |
| 111 | Type II lissencephaly (HP:0007260) | 1.87622360 |
| 112 | Glycosuria (HP:0003076) | 1.87150764 |
| 113 | Abnormality of urine glucose concentration (HP:0011016) | 1.87150764 |
| 114 | Colon cancer (HP:0003003) | 1.83884742 |
| 115 | Megaloblastic anemia (HP:0001889) | 1.83582097 |
| 116 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.83474851 |
| 117 | Thrombocytosis (HP:0001894) | 1.83124108 |
| 118 | Large for gestational age (HP:0001520) | 1.82901511 |
| 119 | Abnormality of placental membranes (HP:0011409) | 1.82678179 |
| 120 | Amniotic constriction ring (HP:0009775) | 1.82678179 |
| 121 | Hyperphosphaturia (HP:0003109) | 1.82398985 |
| 122 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.82000386 |
| 123 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.80704719 |
| 124 | Cellular immunodeficiency (HP:0005374) | 1.80515950 |
| 125 | Tubular atrophy (HP:0000092) | 1.80178869 |
| 126 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.80063466 |
| 127 | Anophthalmia (HP:0000528) | 1.79954566 |
| 128 | Abnormal protein glycosylation (HP:0012346) | 1.79905794 |
| 129 | Abnormal glycosylation (HP:0012345) | 1.79905794 |
| 130 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.79905794 |
| 131 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.79905794 |
| 132 | Dicarboxylic aciduria (HP:0003215) | 1.79814851 |
| 133 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.79814851 |
| 134 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.79145397 |
| 135 | Absent forearm bone (HP:0003953) | 1.78917861 |
| 136 | Aplasia involving forearm bones (HP:0009822) | 1.78917861 |
| 137 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.78617759 |
| 138 | Selective tooth agenesis (HP:0001592) | 1.78399688 |
| 139 | Vaginal atresia (HP:0000148) | 1.77817060 |
| 140 | Premature ovarian failure (HP:0008209) | 1.76981114 |
| 141 | Genital tract atresia (HP:0001827) | 1.76973869 |
| 142 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.76882447 |
| 143 | Chronic hepatic failure (HP:0100626) | 1.75936204 |
| 144 | Progressive muscle weakness (HP:0003323) | 1.75528213 |
| 145 | Hypobetalipoproteinemia (HP:0003563) | 1.74628897 |
| 146 | Generalized aminoaciduria (HP:0002909) | 1.74279270 |
| 147 | Triphalangeal thumb (HP:0001199) | 1.73409351 |
| 148 | Abolished electroretinogram (ERG) (HP:0000550) | 1.72028983 |
| 149 | Renal cortical cysts (HP:0000803) | 1.70099159 |
| 150 | Supernumerary spleens (HP:0009799) | 1.69448802 |
| 151 | Confusion (HP:0001289) | 1.69051352 |
| 152 | CNS demyelination (HP:0007305) | 1.68960480 |
| 153 | Partial duplication of the phalanx of hand (HP:0009999) | 1.68879154 |
| 154 | Abnormality of renal resorption (HP:0011038) | 1.68851964 |
| 155 | Horseshoe kidney (HP:0000085) | 1.68019656 |
| 156 | Chorioretinal atrophy (HP:0000533) | 1.67524802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.62135058 |
| 2 | VRK2 | 4.34572102 |
| 3 | BUB1 | 4.31040410 |
| 4 | EIF2AK1 | 3.56601534 |
| 5 | WEE1 | 3.34797528 |
| 6 | STK16 | 2.92882297 |
| 7 | PIM2 | 2.76451598 |
| 8 | PBK | 2.72558288 |
| 9 | EIF2AK3 | 2.71450573 |
| 10 | FRK | 2.64691751 |
| 11 | ADRBK2 | 2.49517127 |
| 12 | SRPK1 | 2.29755926 |
| 13 | PLK4 | 2.27639844 |
| 14 | TAF1 | 2.23618524 |
| 15 | TESK2 | 2.20225559 |
| 16 | NUAK1 | 2.17028513 |
| 17 | VRK1 | 2.14456947 |
| 18 | GRK1 | 2.04621161 |
| 19 | TLK1 | 1.88944865 |
| 20 | EPHA2 | 1.87457653 |
| 21 | ACVR1B | 1.82833406 |
| 22 | EPHB2 | 1.80326768 |
| 23 | RPS6KB2 | 1.73032852 |
| 24 | WNK4 | 1.69457644 |
| 25 | TESK1 | 1.69319747 |
| 26 | CDC7 | 1.68835367 |
| 27 | MYLK | 1.60520946 |
| 28 | BCKDK | 1.58458356 |
| 29 | MAP3K12 | 1.58213143 |
| 30 | MST4 | 1.57066018 |
| 31 | WNK3 | 1.57055322 |
| 32 | INSRR | 1.55417228 |
| 33 | IRAK3 | 1.53044858 |
| 34 | BRSK2 | 1.46645937 |
| 35 | DYRK3 | 1.44593748 |
| 36 | KDR | 1.42476164 |
| 37 | MAP4K2 | 1.41863477 |
| 38 | ABL2 | 1.36301869 |
| 39 | MST1R | 1.35465678 |
| 40 | PLK1 | 1.35172478 |
| 41 | TTK | 1.34683148 |
| 42 | AURKB | 1.31862651 |
| 43 | RPS6KA4 | 1.24156993 |
| 44 | TNIK | 1.21834765 |
| 45 | EIF2AK2 | 1.21792648 |
| 46 | ZAK | 1.21431849 |
| 47 | NME1 | 1.20798708 |
| 48 | LIMK1 | 1.18977139 |
| 49 | MAP3K11 | 1.13207427 |
| 50 | CDK7 | 1.12760975 |
| 51 | MAPKAPK3 | 1.11098482 |
| 52 | AURKA | 1.09424693 |
| 53 | MAP3K8 | 1.08218082 |
| 54 | NEK2 | 1.06619394 |
| 55 | LRRK2 | 1.05778261 |
| 56 | PINK1 | 1.05720542 |
| 57 | STK39 | 1.05661558 |
| 58 | TIE1 | 1.03858469 |
| 59 | MKNK1 | 1.02465819 |
| 60 | PNCK | 0.98822600 |
| 61 | CASK | 0.97842724 |
| 62 | MUSK | 0.97532886 |
| 63 | OXSR1 | 0.96624947 |
| 64 | IKBKB | 0.96477443 |
| 65 | PIK3CA | 0.96437992 |
| 66 | IRAK4 | 0.96215387 |
| 67 | CDK19 | 0.95222359 |
| 68 | ADRBK1 | 0.92447001 |
| 69 | DYRK2 | 0.92149516 |
| 70 | PIM1 | 0.91654384 |
| 71 | STK4 | 0.90201319 |
| 72 | BRAF | 0.88667941 |
| 73 | BLK | 0.87611236 |
| 74 | TYK2 | 0.86170109 |
| 75 | GRK7 | 0.85939601 |
| 76 | PLK2 | 0.83806754 |
| 77 | ATR | 0.80337990 |
| 78 | PAK4 | 0.79308385 |
| 79 | MAP3K3 | 0.78944603 |
| 80 | PIK3CG | 0.78390695 |
| 81 | ARAF | 0.77627676 |
| 82 | PRKCG | 0.77337601 |
| 83 | RPS6KA5 | 0.76535297 |
| 84 | MET | 0.75826000 |
| 85 | CSNK1G3 | 0.74907621 |
| 86 | CSNK1G1 | 0.74117051 |
| 87 | SCYL2 | 0.73353167 |
| 88 | CHEK2 | 0.73161795 |
| 89 | MAP2K7 | 0.72380555 |
| 90 | PAK1 | 0.71961584 |
| 91 | CSNK1G2 | 0.71090707 |
| 92 | CSNK2A1 | 0.70653621 |
| 93 | PASK | 0.70530846 |
| 94 | NEK9 | 0.69819644 |
| 95 | STK10 | 0.69657462 |
| 96 | NEK1 | 0.68798172 |
| 97 | MAP3K14 | 0.68346857 |
| 98 | MAPKAPK5 | 0.68305531 |
| 99 | PRKCE | 0.66484964 |
| 100 | CSNK1A1L | 0.66182559 |
| 101 | PLK3 | 0.65978066 |
| 102 | MAP2K2 | 0.65824579 |
| 103 | MAPK15 | 0.64447730 |
| 104 | PAK3 | 0.63757141 |
| 105 | CSNK2A2 | 0.62882467 |
| 106 | STK38L | 0.62656353 |
| 107 | FLT3 | 0.61067947 |
| 108 | MAP3K4 | 0.60803650 |
| 109 | PDK2 | 0.59561525 |
| 110 | TGFBR1 | 0.59484171 |
| 111 | CAMKK2 | 0.58594823 |
| 112 | ILK | 0.56438415 |
| 113 | TBK1 | 0.56069956 |
| 114 | TEC | 0.53238798 |
| 115 | CDK4 | 0.53147892 |
| 116 | BRSK1 | 0.52194204 |
| 117 | TSSK6 | 0.45734465 |
| 118 | CHEK1 | 0.45147403 |
| 119 | CDK8 | 0.44982139 |
| 120 | MOS | 0.44579273 |
| 121 | DDR2 | 0.41018245 |
| 122 | AKT3 | 0.40904409 |
| 123 | ERN1 | 0.39649630 |
| 124 | JAK3 | 0.39624410 |
| 125 | FGFR2 | 0.39445346 |
| 126 | PRKCI | 0.39327029 |
| 127 | GRK5 | 0.39059134 |
| 128 | MKNK2 | 0.38543401 |
| 129 | ERBB4 | 0.37802506 |
| 130 | BCR | 0.37645304 |
| 131 | CSNK1A1 | 0.37146990 |
| 132 | DAPK3 | 0.36737142 |
| 133 | PAK2 | 0.35858251 |
| 134 | LATS2 | 0.35187408 |
| 135 | BTK | 0.34793339 |
| 136 | LYN | 0.34583865 |
| 137 | TRPM7 | 0.34313549 |
| 138 | MELK | 0.33167181 |
| 139 | PRKACA | 0.31233826 |
| 140 | CDK6 | 0.31231411 |
| 141 | TXK | 0.31061696 |
| 142 | ATM | 0.30112214 |
| 143 | BMPR1B | 0.28822593 |
| 144 | MAPKAPK2 | 0.27708919 |
| 145 | STK3 | 0.27542460 |
| 146 | DYRK1B | 0.27525927 |
| 147 | CHUK | 0.26452264 |
| 148 | * CDK2 | 0.22412137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Ribosome_Homo sapiens_hsa03010 | 5.04647487 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.17496045 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.33385222 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.28124233 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.69984531 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.59342453 |
| 7 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.42045925 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 2.29930146 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.29812017 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.18210506 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.09676537 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.04181249 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.03806653 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.01346813 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.86290788 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.83057189 |
| 17 | RNA transport_Homo sapiens_hsa03013 | 1.82710416 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.82092080 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.80400575 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.76431522 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50761305 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.48992151 |
| 23 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.36653717 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.36168919 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.34084041 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.32377678 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.32326229 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.32003846 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.27308792 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.27193376 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.24054823 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20843041 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20710257 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.20061429 |
| 35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.18555259 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17715774 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.16970648 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14456523 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12616575 |
| 40 | Purine metabolism_Homo sapiens_hsa00230 | 1.09809069 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08493540 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 1.05026244 |
| 43 | Phototransduction_Homo sapiens_hsa04744 | 1.03757761 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.00412191 |
| 45 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95767562 |
| 46 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.94864828 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91410774 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87363243 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86630353 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85735945 |
| 51 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84470560 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80749262 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79621176 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.78328243 |
| 55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76583119 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.76272828 |
| 57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75673930 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 0.74878938 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72718534 |
| 60 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.72351042 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72116121 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.71645768 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71632947 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71590679 |
| 65 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.71364828 |
| 66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70909124 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.70830654 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70581692 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.69082816 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68433010 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67464122 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67083409 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66550429 |
| 74 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65424161 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64808516 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64806174 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64423903 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63926489 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.63535863 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62964334 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62141646 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59821882 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.59224348 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57587957 |
| 85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56140515 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.55841415 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55184994 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54298406 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53714466 |
| 90 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.52688484 |
| 91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51314923 |
| 92 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50126254 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49891408 |
| 94 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48018388 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47635194 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45949401 |
| 97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45594420 |
| 98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41972050 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38493387 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37728345 |
| 101 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37645089 |
| 102 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37391090 |
| 103 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37294142 |
| 104 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37239522 |
| 105 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.36798322 |
| 106 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35866181 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.35335510 |
| 108 | Asthma_Homo sapiens_hsa05310 | 0.35315117 |
| 109 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.35129533 |
| 110 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.34947319 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34822818 |
| 112 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32920040 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.32529466 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.31919833 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29319911 |
| 116 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.28562401 |
| 117 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.28450611 |
| 118 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28389346 |
| 119 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.27634313 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27091343 |
| 121 | Nicotine addiction_Homo sapiens_hsa05033 | 0.27062818 |
| 122 | Measles_Homo sapiens_hsa05162 | 0.26917819 |
| 123 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.26785036 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26435054 |
| 125 | Malaria_Homo sapiens_hsa05144 | 0.25403749 |
| 126 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23913176 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.23282313 |
| 128 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.22780740 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.21856933 |

